Correlation Between Health Biotchnology and Origin Emerging

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Origin Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Origin Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Biotchnology Portfolio and Origin Emerging Markets, you can compare the effects of market volatilities on Health Biotchnology and Origin Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Origin Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Origin Emerging.

Diversification Opportunities for Health Biotchnology and Origin Emerging

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Health and Origin is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Origin Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Origin Emerging Markets and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Origin Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Origin Emerging Markets has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Origin Emerging go up and down completely randomly.

Pair Corralation between Health Biotchnology and Origin Emerging

Assuming the 90 days horizon Health Biotchnology Portfolio is expected to under-perform the Origin Emerging. In addition to that, Health Biotchnology is 1.01 times more volatile than Origin Emerging Markets. It trades about -0.19 of its total potential returns per unit of risk. Origin Emerging Markets is currently generating about -0.03 per unit of volatility. If you would invest  1,063  in Origin Emerging Markets on September 30, 2024 and sell it today you would lose (16.00) from holding Origin Emerging Markets or give up 1.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Health Biotchnology Portfolio  vs.  Origin Emerging Markets

 Performance 
       Timeline  
Health Biotchnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Origin Emerging Markets 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Origin Emerging Markets has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Origin Emerging is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Health Biotchnology and Origin Emerging Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Biotchnology and Origin Emerging

The main advantage of trading using opposite Health Biotchnology and Origin Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Origin Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Origin Emerging will offset losses from the drop in Origin Emerging's long position.
The idea behind Health Biotchnology Portfolio and Origin Emerging Markets pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEOs Directory
Screen CEOs from public companies around the world